Lumexa Imaging CEO to Present at 44th Annual J.P. Morgan Healthcare Conference
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 05 2026
0mins
Should l Buy LMRI?
Source: PRnewswire
- Executive Participation: Lumexa Imaging's CEO Caitlin Zulla and CFO Tony Martin will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, highlighting the company's leadership in outpatient imaging services.
- Market Position: As of September 30, 2025, Lumexa Imaging operates 184 imaging centers, making it the second-largest outpatient imaging service provider in the U.S., underscoring its significance in the rapidly growing healthcare market.
- Partnerships: The company has established eight joint ventures with health systems, further enhancing its market reach and service capabilities, aiming to improve accessibility and quality of healthcare services through collaboration.
- Investor Relations: Lumexa Imaging provides an online webcast link and related presentation materials, aiming to enhance engagement with investors through transparent information sharing, thereby improving the company's image and trust in the capital markets.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy LMRI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on LMRI
Wall Street analysts forecast LMRI stock price to rise
8 Analyst Rating
8 Buy
0 Hold
0 Sell
Strong Buy
Current: 15.990
Low
22.00
Averages
22.71
High
23.00
Current: 15.990
Low
22.00
Averages
22.71
High
23.00
About LMRI
Lumexa Imaging Holdings, Inc. is a national provider of diagnostic imaging services. The Company offers a range of advanced imaging services (MRI, CT and PET scans) and routine diagnostic and screening imaging services (X-ray, ultrasound and mammography). The Company’s segments include Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The Outpatient segment consists of imaging centers that are owned or operated by it (either wholly owned or via unconsolidated affiliate), where it performs the imaging scan and provides the radiologist’s interpretation service. The Professional segment consists of professional interpretation services, where the imaging scan itself is performed at the hospital or point of care and not by it or its unconsolidated affiliates. The Company and its affiliates operate outpatient imaging center footprint in the United States, spanning 184 centers across 13 states and includes eight joint venture partnerships with health systems.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Investor Conference Participation: Lumexa Imaging's CEO Caitlin Zulla and CFO Tony Martin will participate in upcoming investor conferences, showcasing the company's leadership in the imaging sector, which is expected to attract investor interest.
- Business Scale: With over 5,000 employees and 185 outpatient imaging centers nationwide, Lumexa Imaging conducted approximately 4 million outpatient scans in 2024, demonstrating its strong capabilities and market share in the medical imaging services sector.
- Technological Edge: The company is committed to delivering best-in-class clinical excellence, operational efficiency, and state-of-the-art technology, further solidifying its position as the partner of choice for health systems and radiologists, driving future business growth.
- Forward-Looking Statements: The press release includes forward-looking statements regarding future business strategies and management plans, cautioning investors to consider the potential risks and uncertainties associated with these statements.
See More
- Investor Conference Participation: Lumexa Imaging's CEO Caitlin Zulla and CFO Tony Martin are set to participate in several upcoming investor conferences in Florida, showcasing the company's leadership in the outpatient imaging sector.
- Conference Schedule: They will present at the Raymond James Institutional Investors Conference on March 2, 2026, followed by participation in the Leerink Partners Global Healthcare Conference on March 9 and the Barclays 28th Annual Global Healthcare Conference on March 10, enhancing the company's visibility.
- Business Scale and Impact: With over 5,000 employees and 185 imaging centers nationwide, Lumexa Imaging conducted approximately 4 million outpatient scans in 2024, highlighting its significant role in the imaging services market and likely attracting more investor interest.
- Forward-Looking Statements: The company’s press release includes forward-looking statements that outline potential risks related to future business strategies and management plans, advising investors to approach these statements with caution to avoid over-reliance on projected performance.
See More
- Leadership Change: Dr. Jennifer L. Kemp, Chair of Lumexa Imaging's Center for Quality, has been elected to the Board of Directors of the Radiological Society of North America, reflecting the company's clinical leadership and the vital role of physicians in radiology.
- Patient Experience Enhancement: In her role as Chief of Patient Experience at Scanslated, Dr. Kemp leads initiatives to improve patient understanding of radiology results, showcasing the company's commitment to innovation in patient engagement.
- Technology Platform Utilization: Lumexa Imaging has utilized Scanslated's AI-driven software to provide over 2 million patients with clear radiology reports, significantly enhancing their likelihood of choosing Lumexa Imaging centers in the future.
- Industry Development Commitment: Dr. Kemp's role at RSNA will help guide the future of radiology, ensuring high-quality patient care while strengthening the voice of radiologists, aligning with Lumexa Imaging's commitment to clinical excellence and patient experience.
See More
- Network Expansion: Lumexa Imaging set a company record by opening nine new imaging centers in 2025, increasing its total to over 185 centers across 13 states, significantly enhancing its market coverage and service capabilities nationwide.
- Strategic Growth: The new centers not only strengthen Lumexa Imaging's presence in rapidly growing metropolitan areas but also meet the rising patient demand for high-quality, cost-effective imaging services, driving future revenue growth for the company.
- Patient-Centric Approach: The company is focused on improving patient experiences by extending operating hours and providing easily accessible retail locations, which enhances patient satisfaction and strengthens its competitive position in the market.
- Future Outlook: Lumexa Imaging plans to continue expanding its network of imaging centers in 2026, further solidifying its leadership in the national imaging services market and is expected to deliver sustained growth and returns for shareholders.
See More
- Network Expansion: Lumexa Imaging set a record by opening nine new imaging centers in 2025, increasing its total to over 185 centers across 13 states, significantly enhancing the company's market coverage and service capabilities nationwide.
- Patient Service Enhancement: The new centers not only improve the patient experience for imaging exams but also make it easier for patients to complete MRIs, CTs, and PET/CTs through extended hours and convenient retail locations, thereby increasing accessibility to healthcare services.
- Strategic Growth: The Chief Growth Officer stated that Lumexa Imaging's de novo growth strategy focuses on high-growth metropolitan statistical areas, which is expected to continue driving business growth in 2026 and further solidify its position as the second-largest provider in the imaging services market.
- Future Outlook: With an aging population and rising chronic conditions, Lumexa Imaging plans to continue opening more new centers in collaboration with joint venture partners to meet the increasing healthcare demand, ensuring sustained value for both shareholders and patients.
See More
- Executive Participation: Lumexa Imaging's CEO Caitlin Zulla and CFO Tony Martin will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, highlighting the company's leadership in outpatient imaging services.
- Market Position: As of September 30, 2025, Lumexa Imaging operates 184 imaging centers, making it the second-largest outpatient imaging service provider in the U.S., underscoring its significance in the rapidly growing healthcare market.
- Partnerships: The company has established eight joint ventures with health systems, further enhancing its market reach and service capabilities, aiming to improve accessibility and quality of healthcare services through collaboration.
- Investor Relations: Lumexa Imaging provides an online webcast link and related presentation materials, aiming to enhance engagement with investors through transparent information sharing, thereby improving the company's image and trust in the capital markets.
See More










